Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open-Label Trial of MucoLock™ Oral Rinse for the Treatment of Stomatitis Characterized by Oral Dysesthesia

NCT07506018 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT07506018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07506018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open-Label Trial of MucoLock™ Oral Rinse for the Treatment of Stomatitis Characterized by Oral Dysesthesia
Lead sponsor
Baptist Health South Florida
Phase
Not applicable
Overall status
Recruiting
Start date
July 16, 2026
Completion date
August 31, 2028
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burning mouth, burning mouth syndrome, oral dysesthesia, pain, stomatitis